Goldstein Dov A Md - Net Worth and Insider Trading
Goldstein Dov A Md Net Worth
The estimated net worth of Goldstein Dov A Md is at least $2 Million dollars as of 2024-11-13. Goldstein Dov A Md is the Director of Esperion Therapeutics Inc and owns about 837,125 shares of Esperion Therapeutics Inc (ESPR) stock worth over $2 Million. Goldstein Dov A Md is the Director of Coya Therapeutics Inc and owns about 10,000 shares of Coya Therapeutics Inc (COYA) stock worth over $72,500. Goldstein Dov A Md is also the Director of NeuBase Therapeutics Inc and owns about 500 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $189. Details can be seen in Goldstein Dov A Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Goldstein Dov A Md has not made any transactions after 2023-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Goldstein Dov A Md
Goldstein Dov A Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Goldstein Dov A Md owns 7 companies in total, including NeuBase Therapeutics Inc (NBSE) , ADMA Biologics Inc (ADMA) , and Esperion Therapeutics Inc (ESPR) among others .
Click here to see the complete history of Goldstein Dov A Md’s form 4 insider trades.
Insider Ownership Summary of Goldstein Dov A Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-04-30 | director |
| ADMA | ADMA Biologics Inc | 2012-02-13 | director |
| ESPR | Esperion Therapeutics Inc | 2017-03-22 | director |
 | | 2017-03-07 | director |
| | 2015-04-01 | 10 percent owner & CFO and Treasurer |
| | 2021-03-17 | director |
| | 2023-01-03 | director |
Goldstein Dov A Md Latest Holdings Summary
Goldstein Dov A Md currently owns a total of 3 stocks. Among these stocks, Goldstein Dov A Md owns 837,125 shares of Esperion Therapeutics Inc (ESPR) as of March 22, 2017, with a value of $2 Million and a weighting of 96.56%. Goldstein Dov A Md owns 10,000 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $72,500 and a weighting of 3.43%. Goldstein Dov A Md also owns 500 shares of NeuBase Therapeutics Inc (NBSE) as of April 30, 2020, with a value of $189 and a weighting of 0.01%.
Latest Holdings of Goldstein Dov A Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2017-03-22 | 837,125 | 2.44 | 2,038,399 |
| COYA | Coya Therapeutics Inc | 2023-01-03 | 10,000 | 7.25 | 72,500 |
| NBSE | NeuBase Therapeutics Inc | 2020-04-30 | 500 | 0.38 | 189 |
Holding Weightings of Goldstein Dov A Md
Goldstein Dov A Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 800,000 shares on March 22, 2017, which brought Goldstein Dov A Md around $33 Million.
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 10,000 shares on January 3, 2023, which cost Goldstein Dov A Md around $46,500.
According to the SEC Form 4 filings, Goldstein Dov A Md has made a total of 1 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 500 shares on April 30, 2020, which cost Goldstein Dov A Md around $60,000.
Insider Trading History of Goldstein Dov A Md
- 1
Goldstein Dov A Md Trading Performance
GuruFocus tracks the stock performance after each of Goldstein Dov A Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goldstein Dov A Md is 8.84%. GuruFocus also compares Goldstein Dov A Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goldstein Dov A Md within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Goldstein Dov A Md's insider trading performs compared to the benchmark.
Performance of Goldstein Dov A Md
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.19 | | | | | |
| Relative Return to S&P 500(%) | -0.94 | | | | | |
Goldstein Dov A Md Ownership Network
Ownership Network List of Goldstein Dov A Md
Ownership Network Relation of Goldstein Dov A Md
Goldstein Dov A Md Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
Goldstein Dov A Md is the director of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, Goldstein Dov A Md made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
Goldstein Dov A Md Mailing Address
Above is the net worth, insider trading, and ownership report for Goldstein Dov A Md. Currently GuruFocus does not have mailing address information for Goldstein Dov A Md.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
